In a study in which juvenile dogs received lisdexamfetamine dimesylate for 6 months beginning at 10 weeks of age, decreased bodyweight gain was seen at all doses tested (2, 5, and 12 mg/kg/day, which are approximately 0.5, 1, and 3 times the maximum recommended human daily dose on a mg/m2 basis for a child)
7 Obesity is the strongest risk factor for type 2 diabetes, 8 , 9 a major contributor to insulin resistance, 2 , 10 and is involved in the pathophysiology of hypertension, dyslipidaemia and nonalcoholic fatty liver disease
Adjusting prescription quantities or connecting patients with patient assistance programs may help ensure consistent access to viable medication
Your GP or specialist will typically review your progress every three to six months, checking weight loss, tolerability, and any changes in your medical conditions or medications